Avet Lifesciences Company Profile
What is the competitive landscape for AVET LIFESCIENCES
AVET LIFESCIENCES has thirty-nine approved drugs.
Drugs and US Patents for Avet Lifesciences
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | ZOLEDRONIC ACID | zoledronic acid | INJECTABLE;INTRAVENOUS | 201783-001 | Mar 12, 2013 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Avet Lifesciences | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 202313-002 | Sep 15, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Avet Lifesciences | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 202274-001 | Oct 31, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Avet Lifesciences | PROPOFOL | propofol | INJECTABLE;INJECTION | 206408-001 | Oct 12, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Avet Lifesciences | IBUTILIDE FUMARATE | ibutilide fumarate | INJECTABLE;INJECTION | 204146-001 | Apr 1, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Avet Lifesciences | ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride | INJECTABLE;INJECTION | 212189-001 | Nov 19, 2021 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Avet Lifesciences | FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 203428-001 | Aug 26, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

